公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
1995 | Prevalence, Genotypes and Antibody Titer of Hepatitis C Virus in Pregnant Women in Taiwan | HO-HSIUNG LIN ; JIA-HORNG KAO ; Huang S. C.; Lee T. Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of Obstetrics and Gynaecology | 7 | 0 | |
2021 | Prevention of hepatitis b virus-related hepatocellular carcinoma | Lin C.-L.; JIA-HORNG KAO | Hepatoma Research | 15 | 15 | |
2009 | Prevention of hepatocellular carcinoma in hepatitis B virus infection | Lim S.G.; Mohammed R.; Yuen M.-F.; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 63 | 61 | |
2018 | Prevention of mother-to-child transmission: the key of hepatitis B virus elimination | Lin C.-L.; JIA-HORNG KAO | Hepatology International | 5 | 5 | |
2001 | Probable reinfection with hepatitis C virus in a chronic hepatitis C patient with a sustained response to combination therapy | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; DING-SHINN CHEN | Journal of the Formosan Medical Association | 9 | 9 | |
2019 | Profile and value of FIB-4 in patients with dual chronic hepatitis C and B | CHUN-JEN LIU ; TAI-CHUNG TSENG ; Yang W.-T; TUNG-HUNG SU ; HUNG-CHIH YANG ; CHEN-HUA LIU ; PEI-JER CHEN ; DING-SHINN CHEN ; JIA-HORNG KAO | Journal of Gastroenterology and Hepatology (Australia) | 10 | 9 | |
2013 | Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype | Huang C.-F.; Yu M.-L.; JIA-HORNG KAO ; TAI-CHUNG TSENG ; Yeh M.-L.; Huang J.-F.; Dai C.-Y.; Lin Z.-Y.; Chen S.-C.; Wang L.-Y.; Juo S.H.H.; Chuang W.-L.; CHEN-HUA LIU | Journal of Clinical Virology | 16 | 17 | |
2020 | Progress towards elimination goals for viral hepatitis | Cox A.L.; El-Sayed M.H.; JIA-HORNG KAO ; Lazarus J.V.; Lemoine M.; Lok A.S.; Zoulim F. | Nature Reviews Gastroenterology and Hepatology | 96 | 92 | |
2022 | Progression Rates by Age, Sex, Treatment, and Disease Activity by AASLD and EASL Criteria: Data for Precision Medicine | Park J.; Le A.K.; TAI-CHUNG TSENG ; Yeh M.-L.; Jun D.W.; Trinh H.; Wong G.L.H.; Chen C.-H.; Peng C.-Y.; Kim S.E.; Oh H.; Kwak M.-S.; Cheung K.S.; Toyoda H.; Hsu Y.-C.; Jeong J.Y.; Yoon E.L.; Ungtrakul T.; Zhang J.; Xie Q.; Ahn S.B.; Enomoto M.; Shim J.-J.; Cunningham C.; Jeong S.W.; Cho Y.K.; Ogawa E.; Huang R.; Lee D.-H.; Takahashi H.; Tsai P.-C.; Huang C.-F.; Dai C.-Y.; Tseng C.-H.; Yasuda S.; Kozuka R.; Li J.; Wong C.; Wong C.C.; Zhao C.; Hoang J.; Eguchi Y.; Wu C.; Tanaka Y.; Gane E.; Tanwandee T.; Cheung R.; Yuen M.-F.; Lee H.-S.; Yu M.-L.; JIA-HORNG KAO ; Yang H.-I.; Nguyen M.H. | Clinical Gastroenterology and Hepatology | 3 | 4 | |
2001 | Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: A clinical trial of interferon relapsers and non-responders | JIA-HORNG KAO ; Lai M.-Y.; PEI-JER CHEN ; Cheng Y.-M.; DING-SHINN CHEN | Journal of the Formosan Medical Association | 0 | 2 | |
1995 | Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non-structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C | PEI-MING YANG ; Hwang L.-H.; Lai M.-Y.; Huang W.-L.; Chu Y.-D.; Chi W.-K.; BOR-LUEN CHIANG ; JIA-HORNG KAO ; PEI-JER CHEN ; DING-SHINN CHEN | Clinical and Experimental Immunology | 8 | 7 | |
2003 | A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation | CHUN-JEN LIU ; PEI-JER CHEN ; Lai M.-Y.; JIA-HORNG KAO ; Chang C.-F.; Wu H.-L.; Shau W.-Y.; DING-SHINN CHEN | Gastroenterology | 58 | 54 | |
2022 | Prothrombin induced by vitamin K absence or antagonist-II (PIVKA-II) predicts complete responses of transarterial chemoembolization for hepatocellular carcinoma | Wang, Sung-Yin; TUNG-HUNG SU ; BANG-BIN CHEN ; CHUN-JEN LIU ; CHEN-HUA LIU ; HUNG-CHIH YANG ; TAI-CHUNG TSENG ; PEI-JER CHEN ; JIA-HORNG KAO | Journal of the Formosan Medical Association = Taiwan yi zhi | 4 | 4 | |
2004 | Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis | Shiou-Hwei Yeh ; Tsai C.-Y.; JIA-HORNG KAO ; CHUN-JEN LIU ; Kuo T.-J.; Lin M.-W.; Huang W.-L.; Lu S.-F.; Jih J.; DING-SHINN CHEN ; PEI-JER CHEN | Journal of Hepatology | 193 | 182 | |
2019 | Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus | HUNG-CHIH YANG ; JIA-HORNG KAO | Gut | 4 | 2 | |
2019 | Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done | Hsu Y.-C.; Tseng C.-H.; JIA-HORNG KAO | Clinical Gastroenterology and Hepatology | 5 | 2 | |
2018 | Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B | Tseng C.-H.; Hsu Y.-C.; Chang C.-Y.; TAI-CHUNG TSENG ; MING-SHIANG WU ; Lin J.-T.; JIA-HORNG KAO | Journal of the Formosan Medical Association | 29 | 26 | |
2013 | Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients | Yuan Q.; Song L.-W.; CHUN-JEN LIU ; Li Z.; Liu P.-G.; Huang C.-H.; Yan Y.; Ge S.-X.; Wang Y.-B.; Peng C.-Y.; Zhang J.; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Gut | 67 | 63 | |
2015 | Quantitative hepatitis B core antibody levels in the natural history of hepatitis B virus infection | Song L.-W.; Liu P.-G; CHUN-JEN LIU ; Zhang T.-Y; Cheng X.-D; Wu H.-L; HUNG-CHIH YANG ; Hao X.-K; Yuan Q; Zhang J; JIA-HORNG KAO ; DING-SHINN CHEN ; PEI-JER CHEN ; Xia N.-S. | Clinical Microbiology and Infection | 98 | 86 | |
1995 | Quasispecies of hepatitis c virus and genetic drift of the hypervariable region in chronic type c hepatitis | JIA-HORNG KAO ; PEI-JER CHEN ; Lai M.-Y.; Wang T.-H.; Chen D.-S. | Journal of Infectious Diseases | 47 | 42 |